An optical tomography system was developed that allows the simultaneous bilateral imaging of the breasts' vascular dynamics with a high spatial probing density (2096 measuring channels per wavelength per breast). The system features novel arrays of fiber-optic probes, which afford highfidelity optical contact in a well-defined geometry, and which conform to a wide range of breast shapes and sizes without undue compression or the use of coupling fluids. The sensing arrays use strain gauges to monitor the compression of the breasts and to measure the tissue's reaction to pressuremodulating patient maneuvers.
• Simultaneous dual-breast imaging allows for paired comparison between diseased and healthy tissue, thus increasing statistical robustness [2] • Multitude of hemodynamic metrics may be considered for use as uni-and multivariate disease predictors [3] Previously described instrumentation was used for method evaluation, and demonstrated:
Instrumental feasibility of dual-breast imaging Potentially high diagnostic power for many uni-variate and multivariate diagnostic metrics based on bilateral dynamic contrasts Some practical shortcomings also became clear, which were addressed in the new imager design:
Patients were required to lie prone, which for many was uncomfortable, and which interfered with the proper performance of provocation protocols, such as the quantitative Valsalva maneuver.
fixed-size plastic cups as fiber-optic interface:
⇒ limited anatomical adaptability: good optical contact could be achieved only for a subset of breast sizes and shapes;
⇒ circular cross-section maximizes measuring distances in the coronal plane, thus decreasing the achievable signal-to-noise ratio.
Fairly sparse optode arrangement of 31 sources (S) x 31 detectors (D) per breast. Rigid dualcup probe holder accommodated only limited breast sizes, or only a portion of the breast To alleviate these shortcomings, the new instrument was designed with the following features:
• Cart-based design and probe holders on two articulated arms, for independent positioning of the fibers on each breast, to allow imaging the subject in a comfortable sitting position.
• Increased no. of channels: 32S x 64D per breast (total of 2 x 2048 Ch. x 2 Wavelengths @ 1.8Hz)
• Measuring head design: clamshell mechanism allows mild compression for better transmission accommodates large range of breast sizes allows pressure modulation high spatial sensing density
• Integrated strain gauges measure pressure/displacement of tissue
INSTRUMENTATION
The instrument design (see Fig. 1 ) expands on proven technology described before [4]:
• Detection: 2x 64-channel detector modules with Si photodiodes, adaptive gain switching, and analog lock-in amplification for demodulation of two frequency-encoded wavelengths. Signal sampling by 4 64-analog-channel data acquisition boards (National Instruments PCI 6033).
• Illumination: 2x fiber pigtailed laser diodes (400 mWmax, 760 nm, 830 nm, from High Power Devices, Inc., NJ), combined by dichroic mirrors (OZ Optics, Canada) and focused into a homebuilt optical switch (OS) [2, 4] . OS uses rotating 2-mirror stack for parallel multiplexed illumination of both breasts through two source-fiber arrays. Physical separation of breasts sufficiently suppresses potential optical crosstalk between measuring sites.
• Probe holders: A Clamshell design comprising mechanical fingers to arrange optodes in linear arrays of four (Fig. 1c) on the superior breast surface. The lower half of the device consists of 4 metal fingers, each carrying 8 fibers, forming the lower breast support. Horizontal distance between top and bottom fingers is variable, via a single adjustment screw, to accommodate different breast sizes. The upper half of the clamshell is formed by 8 cantilevered metal rods (Fig  1b,c) which can be adjusted to accommodate different breast sizes and to apply a controlled pressure to the tissue.
• Strain gauges: 8 semiconductor strain gauges (SS-090-060-500P by Micron Instruments, Inc., CA) are incorporated into each measuring head to monitor pressure exerted onto the breast tissue by sensing minute bending in the support rods, causing changes in resistance (Fig. 1d) . Gauge resistance changes linearly with the force applied to the rod (5.7 Ω/N, linearity better than 1% over a range of 15N, see Fig. 1e ). Nominal resting resistance of the devices: 540 Ω @ 25.5°C; load-free mounted resistance (offset) ~ 410 Ω. Individual gauge response differences (stable, within 10%) are calibrated. Gauges are read out with a voltage divider and sampled by a data acquisition board (USB 6218 by National Instruments Corp, TX). Achievable measurement sensitivity is 16 mN.
METHODS
• Subject demographics for the measurements are summarized in Tab. 4
• The dynamic phantom consisted of a malleable silicone rubber, with optical properties matching those of breast tissue, into which electrochromic cells were embedded. Electronic control of the inclusions allows precise mimicking of local changes in Hboxy and Hbred [5] .
• 3D Images were reconstructed with a first-order solution of the diffusion equation [6] • Concentration changes in the reconstructed phantom data were determined with a General Linear Model (GLM)
• Healthy-volunteer measurements using the new setup were analyzed according to a recently described algorithm to extract autoregulatory states of tissue (also see Posters BMD1, BSuE61, BSuE57)
• The prospective patient study performed with the first-generation dual-breast imager was analyzed using a variety of uni-and multivariate disease predicting metrics derived earlier on a training set of patients. The metrics are based on relative left-vs.-right differences for (1) spatiotemporally averaged baseline activity, (2) the spatial synchrony of low-frequency rhythms during baseline, (3) the pressure-induced blood volume and oxygenation shifts (see Fig. 5a ,b and Tab. 1).
• For multivariate predictors, a logistic regression algorithm was used to determine the optimal weighting coefficients.
RESULTS AND DISCUSSION
Validation studies for new imager:
• A FEM mesh of the compressed breast was developed (Fig. 2) . Simulations yield localization of inclusions with high accuracy for the given measurement geometry.
• Phantom measurements demonstrate (1) accurate inclusion localization and (2) highly linear relation between programmed and reconstructed inclusion optical density (Fig. 3 ).
• Healthy volunteer studies demonstrate capability to extract autoregulatory tissue features as shown in Fig. 4 .
⇒ These results demonstrate the new technology's capability of high-fidelity
data capture and functional feature extraction.
⇒ Dense spatial sampling of the breast and good adaptability to various breast sizes were successfully demonstrated.
Prospective clinical study (previous imager):
• Prospective study on 4 patient groups (healthy, non-CA pathology, history of CA, CA)
• Multivariate predictors were derived from results on a previously obtained training set of data
• Whereas multi-variate disease predictors 1-3 in Tab. 2 yielded the best diagnostic power on the training set, they turned out not to be the optimal choice for the test set. Most successful here was a purely wavelet transform-based formulation (row 4 of Tab. 2). We attribute this discrepancy to (1) the age mismatch in the study subgroups from test and training setspecifically training non-CA vs. test CA (p = 0.02) -and (2) a strong mismatch in the numbers of pre-and postmenopausal participants in the CA groups (bias of pre-menopausal women in training set, Tab. 6). We expect to these difficulties in future dataset to be alleviated by larger enrollment numbers.
• Fig. 5c shows a histogram of the computed p values for the most successful metric. The threshold for disease prediction is set at 0.5. It can be seen that while healthy volunteers are all correctly identified, our false positive results occur only for participants in group 2 (other, non-CA lesion) and Group 3 (history of CA). We would like to note that, although at the time of study considered CA-free, pt. 25 was diagnosed with a relapse about a year later so that this FP result could be explained by unknown presence of cancerous tissue at the time of imaging. Tab. 5 lists the lesion details for all our FP and FN cases.
• Predictor no. 4 yields sensitivity and specificity of 81% and 86%, respectively, and positive and negative predictive power of 81% and 86%, respectively. 
